Andtendo
2022-01-18
Like please :)
Moderna CEO says data for Omicron-specific shot likely available in March<blockquote>Moderna首席执行官表示，奥密克戎专用疫苗的数据可能会在三月份提供</blockquote>
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
1
4
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":697685014,"tweetId":"697685014","gmtCreate":1642458929916,"gmtModify":1642458931066,"author":{"id":3577917241557928,"idStr":"3577917241557928","authorId":3577917241557928,"authorIdStr":"3577917241557928","name":"Andtendo","avatar":"https://static.tigerbbs.com/a36b92c865704901397ab4e190d5ad8a","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":24,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Like please :)</p></body></html>","htmlText":"<html><head></head><body><p>Like please :)</p></body></html>","text":"Like please :)","highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/697685014","repostId":2204577605,"repostType":4,"repost":{"id":"2204577605","kind":"highlight","pubTimestamp":1642431461,"share":"https://www.laohu8.com/m/news/2204577605?lang=zh_CN&edition=full","pubTime":"2022-01-17 22:57","market":"us","language":"en","title":"Moderna CEO says data for Omicron-specific shot likely available in March<blockquote>Moderna首席执行官表示，奥密克戎专用疫苗的数据可能会在三月份提供</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2204577605","media":"Reuters","summary":"Moderna Inc's vaccine candidate against the Omicron coronavirus variant will enter clinical developm","content":"<p><html><head></head><body>Moderna Inc's vaccine candidate against the Omicron coronavirus variant will enter clinical development in the next few weeks and the company expects to be able to share data with regulators around March, CEO Stephane Bancel said on Monday.</p><p><blockquote><html><head></head><body>Moderna Inc首席执行官Stephane Bancel周一表示，针对奥密克戎冠状病毒变种的候选疫苗将在未来几周内进入临床开发，该公司预计能够在3月份左右与监管机构共享数据。</body></html></blockquote></p><p>"The vaccine is being finished ... it should be in the clinic in coming weeks. We are hoping in the March timeframe to be able to have data to share with regulators to figure out next steps," Bancel said at the World Economic Forum's virtual Davos Agenda conference.</p><p><blockquote>班塞尔在世界经济论坛上表示：“疫苗正在完成……应该会在未来几周内进入诊所。我们希望在3月份的时间框架内能够与监管机构分享数据，以制定下一步措施。”虚拟达沃斯议程会议。</blockquote></p><p>Moderna is also developing a single vaccine that combines a booster dose against COVID-19 with its experimental flu shot. ()</p><p><blockquote>Moderna还在开发一种单一疫苗，将针对COVID-19的加强剂量与其实验性流感疫苗相结合。()</blockquote></p><p>Bancel said the best case scenario was the combined COVID/flu vaccine would be available by the fall of 2023, at least in some countries.</p><p><blockquote>Bancel表示，最好的情况是新冠/流感联合疫苗将在2023年秋季上市，至少在一些国家是这样。</blockquote></p><p>"Our goal is to be able to have a single annual booster so that we don't have compliance issues where people don't want to get two to three shots a winter."</p><p><blockquote>“我们的目标是能够每年注射一次加强剂，这样我们就不会出现人们不想在冬天注射两到三次的合规性问题。”</blockquote></p><p>Many countries are already offering a third dose of a COVID-19 vaccine to their citizens, especially to older individuals and those who are immunocompromised, while Israel has started offering its citizens a fourth dose.</p><p><blockquote>许多国家已经向其公民提供第三剂新冠肺炎疫苗，特别是老年人和免疫功能低下的人，而以色列已经开始向其公民提供第四剂。</blockquote></p><p>Earlier in January, Moderna's CEO said people may need a fourth shot in the fall of 2022 as the efficacy of boosters against COVID-19 was likely to decline over the next few months.</p><p><blockquote>1月初，Moderna首席执行官表示，人们可能需要在2022年秋季注射第四针，因为针对COVID-19的加强剂的功效可能会在未来几个月下降。</blockquote></p><p>However, booster programs have met with skepticism from some disease experts over whether, and how widely, additional doses should become available, including the European Union's drug regulator, which has expressed doubts about the need for a fourth booster dose.</p><p><blockquote>然而，加强计划遭到了一些疾病专家的怀疑，即是否应该提供额外剂量以及在多大程度上提供额外剂量，包括欧盟药品监管机构，该机构对是否需要第四次加强剂量表示怀疑。</blockquote></p><p>Speaking at the same event, top U.S. infectious disease expert Anthony Fauci said there was no evidence that repeat booster doses would overwhelm the immune system.</p><p><blockquote>在同一活动中，美国顶级传染病专家安东尼·福奇表示，没有证据表明重复加强剂量会压倒免疫系统。</blockquote></p><p>"Giving boosters at different times, there is really no evidence that's going to hinder (immune response)."</p><p><blockquote>“在不同时间注射加强剂，确实没有证据表明会阻碍（免疫反应）。”</blockquote></p><p>Fauci said the goal should be to have a booster that induces a response against multiple potential variants.</p><p><blockquote>福奇说，目标应该是有一种增强剂，可以诱导对多种潜在变种的反应。</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna CEO says data for Omicron-specific shot likely available in March<blockquote>Moderna首席执行官表示，奥密克戎专用疫苗的数据可能会在三月份提供</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna CEO says data for Omicron-specific shot likely available in March<blockquote>Moderna首席执行官表示，奥密克戎专用疫苗的数据可能会在三月份提供</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Reuters</strong><span class=\"h-time small\">2022-01-17 22:57</span>\n</p>\n</h4>\n</header>\n<article>\n<p><html><head></head><body>Moderna Inc's vaccine candidate against the Omicron coronavirus variant will enter clinical development in the next few weeks and the company expects to be able to share data with regulators around March, CEO Stephane Bancel said on Monday.</p><p><blockquote><html><head></head><body>Moderna Inc首席执行官Stephane Bancel周一表示，针对奥密克戎冠状病毒变种的候选疫苗将在未来几周内进入临床开发，该公司预计能够在3月份左右与监管机构共享数据。</body></html></blockquote></p><p>"The vaccine is being finished ... it should be in the clinic in coming weeks. We are hoping in the March timeframe to be able to have data to share with regulators to figure out next steps," Bancel said at the World Economic Forum's virtual Davos Agenda conference.</p><p><blockquote>班塞尔在世界经济论坛上表示：“疫苗正在完成……应该会在未来几周内进入诊所。我们希望在3月份的时间框架内能够与监管机构分享数据，以制定下一步措施。”虚拟达沃斯议程会议。</blockquote></p><p>Moderna is also developing a single vaccine that combines a booster dose against COVID-19 with its experimental flu shot. ()</p><p><blockquote>Moderna还在开发一种单一疫苗，将针对COVID-19的加强剂量与其实验性流感疫苗相结合。()</blockquote></p><p>Bancel said the best case scenario was the combined COVID/flu vaccine would be available by the fall of 2023, at least in some countries.</p><p><blockquote>Bancel表示，最好的情况是新冠/流感联合疫苗将在2023年秋季上市，至少在一些国家是这样。</blockquote></p><p>"Our goal is to be able to have a single annual booster so that we don't have compliance issues where people don't want to get two to three shots a winter."</p><p><blockquote>“我们的目标是能够每年注射一次加强剂，这样我们就不会出现人们不想在冬天注射两到三次的合规性问题。”</blockquote></p><p>Many countries are already offering a third dose of a COVID-19 vaccine to their citizens, especially to older individuals and those who are immunocompromised, while Israel has started offering its citizens a fourth dose.</p><p><blockquote>许多国家已经向其公民提供第三剂新冠肺炎疫苗，特别是老年人和免疫功能低下的人，而以色列已经开始向其公民提供第四剂。</blockquote></p><p>Earlier in January, Moderna's CEO said people may need a fourth shot in the fall of 2022 as the efficacy of boosters against COVID-19 was likely to decline over the next few months.</p><p><blockquote>1月初，Moderna首席执行官表示，人们可能需要在2022年秋季注射第四针，因为针对COVID-19的加强剂的功效可能会在未来几个月下降。</blockquote></p><p>However, booster programs have met with skepticism from some disease experts over whether, and how widely, additional doses should become available, including the European Union's drug regulator, which has expressed doubts about the need for a fourth booster dose.</p><p><blockquote>然而，加强计划遭到了一些疾病专家的怀疑，即是否应该提供额外剂量以及在多大程度上提供额外剂量，包括欧盟药品监管机构，该机构对是否需要第四次加强剂量表示怀疑。</blockquote></p><p>Speaking at the same event, top U.S. infectious disease expert Anthony Fauci said there was no evidence that repeat booster doses would overwhelm the immune system.</p><p><blockquote>在同一活动中，美国顶级传染病专家安东尼·福奇表示，没有证据表明重复加强剂量会压倒免疫系统。</blockquote></p><p>"Giving boosters at different times, there is really no evidence that's going to hinder (immune response)."</p><p><blockquote>“在不同时间注射加强剂，确实没有证据表明会阻碍（免疫反应）。”</blockquote></p><p>Fauci said the goal should be to have a booster that induces a response against multiple potential variants.</p><p><blockquote>福奇说，目标应该是有一种增强剂，可以诱导对多种潜在变种的反应。</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/moderna-ceo-says-data-omicron-135958538.html\">Reuters</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","BK4568":"美国抗疫概念","BK4534":"瑞士信贷持仓","BK4548":"巴美列捷福持仓","BK4535":"淡马锡持仓","BK4139":"生物科技","MRNA":"Moderna, Inc.","BK4532":"文艺复兴科技持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4551":"寇图资本持仓"},"source_url":"https://finance.yahoo.com/news/moderna-ceo-says-data-omicron-135958538.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2204577605","content_text":"Moderna Inc's vaccine candidate against the Omicron coronavirus variant will enter clinical development in the next few weeks and the company expects to be able to share data with regulators around March, CEO Stephane Bancel said on Monday.\"The vaccine is being finished ... it should be in the clinic in coming weeks. We are hoping in the March timeframe to be able to have data to share with regulators to figure out next steps,\" Bancel said at the World Economic Forum's virtual Davos Agenda conference.Moderna is also developing a single vaccine that combines a booster dose against COVID-19 with its experimental flu shot. ()Bancel said the best case scenario was the combined COVID/flu vaccine would be available by the fall of 2023, at least in some countries.\"Our goal is to be able to have a single annual booster so that we don't have compliance issues where people don't want to get two to three shots a winter.\"Many countries are already offering a third dose of a COVID-19 vaccine to their citizens, especially to older individuals and those who are immunocompromised, while Israel has started offering its citizens a fourth dose.Earlier in January, Moderna's CEO said people may need a fourth shot in the fall of 2022 as the efficacy of boosters against COVID-19 was likely to decline over the next few months.However, booster programs have met with skepticism from some disease experts over whether, and how widely, additional doses should become available, including the European Union's drug regulator, which has expressed doubts about the need for a fourth booster dose.Speaking at the same event, top U.S. infectious disease expert Anthony Fauci said there was no evidence that repeat booster doses would overwhelm the immune system.\"Giving boosters at different times, there is really no evidence that's going to hinder (immune response).\"Fauci said the goal should be to have a booster that induces a response against multiple potential variants.","news_type":1,"symbols_score_info":{"832000":1,"832089":1,"832145":1,"832171":1,"832225":1,"832278":1,"832317":1,"832566":1,"832735":1,"832885":1,"BNTX":0.76,"MRNA":0.9}},"isVote":1,"tweetType":1,"viewCount":2090,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":12,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/697685014"}
精彩评论